Bladder Cancer Think Tank Program Schedule August 7-9, 2014 San Diego, CA Collaborating to Move Research Forward Objectives for the 2014 Think Tank: Understanding pathways to novel targeted therapies; exploring multidisciplinary clinics and treatment for elderly patients and; addressing smoking cessation. Thursday, August 7 Santiago I 1:00 – 3:00
Patient Advocacy Session
Loggia 1 (outside Bernardo Ballroom) 3:00 – 4:00 Registration Bernardo Ballroom 4:00 – 5:00 Opening Remarks & BCAN Presentation Diane Z. Quale, Monica Smith, and Gerald McNamara, Bladder Cancer Advocacy Network Andrea Apolo, MD, National Cancer Institute, Chair, Think Tank 2014 Ashish Kamat, MD, MD Anderson Cancer Center, Co-Chair, Think Tank 2014 5:00 – 6:00
“Greatest Challenges and Opportunities in Oncology” Keynote Address and Q&A Clifford A. Hudis, MD, President, American Society of Clinical Oncology
Santiago Courtyard and Ballroom 6:00 – 8:30 Reception, Dinner and Advocate Remarks Friday, August 8 Bernardo Patio 6:30 – 7:00 Continental Breakfast Bernardo Ballroom 7:00 – 8:15 Immunotherapy Discussion Ashish Kamat, MD, MD Anderson Cancer Center, Panel Chair
“Landscape of Immunotherapy for Urothelial Carcinoma” Trinity Bivalacqua, MD, Johns Hopkins “Immune Characterization of Bladder Cancer” William Kim, MD, UNC Chapel Hill “Predicting Response to Intravesical Immunotherapy” Ashish Kamat, MD, MD Anderson Cancer Center “Anti PDL1 therapy in the treatment of advanced bladder cancer” Daniel Petrylak, MD, Yale School of Medicine Bernardo Ballroom 8:30 – 10:30 Panel: Unmet Clinical Needs in the Elderly: A Multidisciplinary Approach Matthew Nielsen, MD, MS, UNC Chapel Hill, and Peter Black, MD, Vancouver Prostate Centre, Co-Chairs “Unmet Clinical Needs in the Elderly: A Multidisciplinary Approach” Peter Black, MD, Vancouver Prostate Centre “Assessing Older Adults with Cancer: Understanding Functional vs Chronological Age” Arti Hurria, MD, City of Hope “Multimodality Bladder Preservation: Curative Treatment and the Older Patient” Noam VanderWalde, MD, University of Tennessee West Cancer Center “Influence of advanced age in management of patients with non-muscle invasive bladder cancer” Robert Svatek, MD, MS, UT Health Sciences Center at San Antonio Discussion and Q&A Bernardo Patio 10:30 – 10:45 Break Bernardo Ballroom 10:45 – 12:30 John Quale Travel Fellows Presentation and Q&A Sia Daneshmand, MD, University of Southern California, Moderator “Stat3 Transgenic Mice as a Model for Human Basal Subtype of Invasive Bladder Cancer” Philip Ho, MD, MD Anderson Cancer Center “Novel Predictive Micro-RNA Signature in the Setting of Selective Trimodality Bladder Preservation Therapy” Tim Lautenschlaeger, MD, The Ohio State University “Characterization of Met Signaling in Urothelial Carcinoma of the Bladder” Young Lee, PhD, National Cancer Institute “Discovery and Validation of Prognostic Genomic-Based Signatures in High-Risk Bladder Cancer Following Cystectomy” Anirban Mitra, MD, PhD, University of Southern California
Bernardo Patio 12:30 – 2:00 Working Group Lunch Meeting Enhancing Enrollment and Design of Bladder Cancer Clinical Trials – Santiago I Non-Muscle Invasive Bladder Cancer – Santiago II Translational Science – Santiago III Patient-Centered Outcomes and Policy – Andalucia I Standardization of Care – Andalucia II Survivorship – Granada (in La Taberna on Saturday) Upper Tract Disease - Valencia Bernardo Ballroom 2:00 – 4:00 Panel: Smoking and Bladder Cancer: Strategies for Successful Intervention David Latini, PhD, Baylor College of Medicine, and Cheryl Lee, MD, University of Michigan, Co-Chairs “Survivor Perspective” Pat Boumansour, Patient Advocate “The Genetics of Nicotine Dependence and the Impact on Treatment Outcomes in Bladder Cancer” Helena Furberg-Barnes, PhD, Memorial Sloan Kettering “The Role of the Physician in Smoking Cessation Initiatives” Jeffrey Bassett, MD, MPH, Kaiser Permanente Southern California “An Effective Smoking Cessation Intervention Led by Urologists” Courtney M. P. Hollowell, MD, Cook County Health and Hospitals System Simulation, Discussion and Q&A 4:00
Afternoon and Dinner on Your Own
Saturday, August 9 Bernardo Patio 6:45 – 7:30 Breakfast Bernardo Ballroom 7:30 – 11:00 Panel: Targeting Novel Pathways in Bladder Cancer David McConkey, PhD, MD Anderson Cancer Center, and William Kim, MD, UNC Chapel Hill, Co-Chairs “Translational opportunities from the TCGA project in muscle invasive bladder cancer” Seth Lerner, MD, Baylor College of Medicine “Identifying Actionable Genomic Alterations in Bladder Cancer” Gopa Iyer, MD, Memorial Sloan Kettering “Identification of heritable genetic risk factors for bladder cancer through genomewide association studies (GWAS)” Ludmila Prokunina-Olsson, PhD, National Cancer Institute Break
“RNA Subtypes of Bladder Cancer and Their Implications” David McConkey, PhD, MD Anderson Cancer Center “Treatment of Advanced Bladder Cancer, Where We’ve Been and How to Move Forward” Maha Hussain, MD, University of Michigan “Translating genomic findings into clinical practice- MATCH-UP and other efforts” Jonathan Rosenberg, MD, Memorial Sloan Kettering 11:15 – 12:45 Working Group Sessions Enhancing Enrollment and Design of Bladder Cancer Clinical Trials – Santiago I Non-Muscle Invasive Bladder Cancer – Santiago II Translational Science – Santiago III Patient-Centered Outcomes and Policy – Andalucia I Standardization of Care – Andalucia II Survivorship – La Taberna Upper Tract Disease - Valencia Bernardo Patio 12:45 – 2:15 General Box Lunch OR Professional Development/Mentor Lunch Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Moderator Bernardo Ballroom 2:30 – 3:30 Working Group Report Out to Full Meeting 3:30 – 4:00
Program Committee and Working Group Chairs Meeting
Bernardo Patio 5:00 – 7:00 Reception and Closing Remarks
